Toggle light / dark theme

Get the latest international news and world events from around the world.

Log in for authorized contributors

Interactive Zebrafish Embryo Single-Cell Atlas

A developmental atlas for genes and cells.

The interplay between genes and cells during the development of a fertilized egg into an embryo is highly complex. Previous methods captured gene activity only in 2D slices, making whole-embryo visualization impossible and offering limited spatial detail, often missing subcellular patterns.

The new method now enables the research team to visualize the activities of thousands of genes throughout the entire embryo and link them to cell maturation and movement. The result is a comprehensive atlas of early development, along with new insights into how genes and cells shape the growing embryo. The study was published in Science.

The team developed a new imaging technology called weMERFISH. It enables the direct measurement of the activity of nearly 500 genes in entire tissues with subcellular resolution.

From these measurements, the researchers created an atlas of early embryonic development. “By combining previous single-cell data with our gene activity measurements, we were able to calculate spatial patterns of thousands of genes and the activity of around 300,000 potential regulatory regions,” says the author. The data are freely accessible through the web platform MERFISHEYES (http://schier.merfisheyes.com). “The atlas is intended as a resource for developmental biologists around the world.”

With the help of the atlas, the researchers were also able to clarify how clear boundaries between different tissues form, for example between muscle and backbone tissue. They discovered a zone of cells in which the activity of many genes changes dramatically and differs from one side to the other.

A comparison of early and later stages showed that these genes are initially active on both sides but later only on one. And there are hardly any cells that cross this boundary. “These boundaries do not arise because cells are intermingled and then sort, but mainly because cells change their genetic program,” says the author.

A single-cell transcriptional reference for the functional and developmental diversity of neonatal innate lymphoid cells

Mononuclear cells (MNCs) were isolated from fresh umbilical cord blood (CB) via a Ficoll gradient (n = 3). Unwanted cells were depleted using biotinylated antibodies (anti-CD3, anti-CD14, anti-CD19, and CD66b) and magnetic beads. The cells were stained to faithfully sort cILC1s (LinCD94CD127+CD117CRTH2), cILC2s (LinCD94CD127+CD117−/+ CRTH2+), cILC3s (LinCD94CD127+CD117+CRTH2), and NK cells (LinCD94+), as previously described.5,7,33 The four individual populations were individually multiplexed, pooled, and stained with Ab-Seq antibodies.

(A) scRNA-seq was performed via the BD Rhapsody protocol.

(B and C) UMAP visualization of sorted populations (B) and individual clusters of CB cILCs and NK cells with color coding of the individual cluster 0–10. The following clusters were identified: 0, CD56dim NK cells (GZMBhigh); 1, CD56dim NK cells (GZMBlow); 2, cILC2s (GATA3); 3, cILC progenitor (KIT); 4, CD56bright NK cells (GZMK); 5, intermediate zone (NK/cILCs); 6, cILC1s (CD5); 7, activated CD56dim NK cells (PCNA); 8, cycling CD56dim NK cells (MKI67); 9, cILC3s (RORC); and 10, CD56dim NK cells (FOXP2) ©.

Cell-type specific TDP-43 pathology in the motor cortex

The hallmarks of cancer comprise six biological capabilities acquired during the multistep development of human tumors. The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease. They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis. Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions.

Evolutionary causes and consequences of gene duplication

Gene duplication is a key evolutionary mechanism, as initially redundant paralogues diverge over time. The authors review how adaptive and non-adaptive forces influence the evolutionary fates of gene duplicates, highlighting the importance of function–fitness relationships and gene expression dynamics.

Adenosine signaling driven by the gut microbiota underlies chronic alcohol-induced anesthetic resistance

Wang et al. demonstrate that long-term alcohol consumption diminishes anesthetic sensitivity via a gut-microbiome-brain pathway. Their findings indicate that alcohol-induced dysbiosis elevates the metabolite adenosine, which subsequently downregulates brain GABAA receptors, thereby compromising anesthetic effectiveness.

Brain scans reveal link between thinner brain cortex regions and higher psychopathic traits

A team of researchers from Spain was curious to know if people with high psychopathic traits have anomalies in the brain’s physical structures, which make them incapable of feeling regret or capable of manipulation and other antisocial behavior. They conducted an experiment in which they interviewed men convicted of intimate partner violence (IPV) and a control group with no history of violence to measure their psychopathic traits, followed by brain scans.

The results showed that men with thinner cortex in certain brain regions—particularly fronto-temporo-parietal areas —tended to display higher antisocial tendencies, regardless of their history of violence.

Fronto-temporo-parietal cortex regions refer to parts of the brain’s outer layer, which houses gray matter and supports functions such as sensory processing, motor control, and higher cognitive activities. The findings further reinforce a broader idea in neuroscience that regions in these brain regions play a major role in shaping behaviors such as callousness, a lack of empathy, and manipulative tendencies.

‘Bugs delivering drugs’: A new approach to colorectal cancer treatment using common food-borne bacteria

Baylor University researchers have developed a novel approach to fight colorectal cancer, using modified bacteria as a courier to deliver potent cancer-killing proteins into tumor cells. Michael S. VanNieuwenhze, Ph.D., FRSC, University Distinguished Professor and chair of the Department of Biology, along with Baylor doctoral students and a colleague at Texas Tech University Health Sciences Center, have published their research in Cell Chemical Biology.

Colorectal cancers accounted for the second-most deaths caused by cancer in 2025, according to the National Cancer Institute, highlighting the importance of new strategies for therapy and treatment.

Building on growth in the use of bacteria as a tool in fighting cancer, VanNieuwenhze and his team attached saporin, a known cancer-killing toxin, to the surface Listeria monocytogenes, which delivers the toxin to tumor cells. Listeria, commonly recognized as a food-borne bacteria, can be modified for express therapeutic purposes while maintaining its ability to penetrate human cells—making it, VanNieuwenhze said, a particularly promising agent in the fight against colorectal cancer.

CSF Proteomic Profiles Associated With White Matter Integrity in Cognitively Normal Older Adults With and Without Amyloid Pathology

Background and ObjectivesIncreasing evidence indicates a potential role of white matter (WM) damage in the onset and progression of Alzheimer disease (AD). However, the biological processes underlying in vivo WM imaging biomarkers remain unclear. We…

New Pancreatic Cancer Treatment Wipes Out Tumors and Blocks Drug Resistance

A triple drug approach that blocks the KRAS pathway at three points eliminated pancreatic tumors and prevented resistance in mouse models.

Existing treatments for pancreatic cancer often stop working within a few months because tumors quickly develop resistance to the drugs. Researchers at Spain’s National Cancer Research Centre (CNIO) report that they have prevented this resistance in animal studies by using a three-drug combination therapy.

The researchers say their findings “pave the way for the design of combined therapies that may improve survival,” although they caution that this progress will not immediately translate into new treatments for patients. Mariano Barbacid, head of the Experimental Oncology Group at CNIO, emphasizes that “we are not yet in a position to carry out clinical trials with this triple therapy.”

/* */